Pulmonologists as the Gatekeepers of Precision Medicine
Presented by: Momen M. Wahidi, MD, FCCP and W. Dean Wallace, MD
Biomarker-driven targeted therapy of patients with NSCLC requires accurate diagnosis and staging. The pulmonary care team must acquire adequate biopsy tissue to enable histology, immunofluorescence and molecular biomarker testing.
Presented in Los Angeles, California - October 2016.
This site uses cookies. By continuing to use this website, you agree to their use. For details, please check our Privacy Policy.